Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Ther Oncolytics ; 27: 288-304, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36458202

ABSTRACT

Antigen heterogeneity that results in tumor antigenic escape is one of the major obstacles to successful chimeric antigen receptor (CAR) T cell therapies in solid tumors including glioblastoma multiforme (GBM). To address this issue and improve the efficacy of CAR T cell therapy for GBM, we developed an approach that combines CAR T cells with inhibitor of apoptosis protein (IAP) antagonists, a new class of small molecules that mediate the degradation of IAPs, to treat GBM. Here, we demonstrated that the IAP antagonist birinapant could sensitize GBM cell lines and patient-derived primary GBM organoids to apoptosis induced by CAR T cell-derived cytokines, such as tumor necrosis factor. Therefore, birinapant could enhance CAR T cell-mediated bystander death of antigen-negative GBM cells, thus preventing tumor antigenic escape in antigen-heterogeneous tumor models in vitro and in vivo. In addition, birinapant could promote the activation of NF-κB signaling pathways in antigen-stimulated CAR T cells, and with a birinapant-resistant tumor model we showed that birinapant had no deleterious effect on CAR T cell functions in vitro and in vivo. Overall, we demonstrated the potential of combining the IAP antagonist birinapant with CAR T cells as a novel and feasible approach to overcoming tumor antigen heterogeneity and enhancing CAR T cell therapy for GBM.

2.
Cells ; 10(9)2021 09 06.
Article in English | MEDLINE | ID: mdl-34571983

ABSTRACT

The metabolic milieu of solid tumors provides a barrier to chimeric antigen receptor (CAR) T-cell therapies. Excessive lactate or hypoxia suppresses T-cell growth, through mechanisms including NADH buildup and the depletion of oxidized metabolites. NADH is converted into NAD+ by the enzyme Lactobacillus brevis NADH Oxidase (LbNOX), which mimics the oxidative function of the electron transport chain without generating ATP. Here we determine if LbNOX promotes human CAR T-cell metabolic activity and antitumor efficacy. CAR T-cells expressing LbNOX have enhanced oxygen as well as lactate consumption and increased pyruvate production. LbNOX renders CAR T-cells resilient to lactate dehydrogenase inhibition. But in vivo in a model of mesothelioma, CAR T-cell's expressing LbNOX showed no increased antitumor efficacy over control CAR T-cells. We hypothesize that T cells in hostile environments face dual metabolic stressors of excessive NADH and insufficient ATP production. Accordingly, futile T-cell NADH oxidation by LbNOX is insufficient to promote tumor clearance.


Subject(s)
Adenosine Triphosphate/metabolism , Multienzyme Complexes/metabolism , NADH, NADPH Oxidoreductases/metabolism , Receptors, Antigen, T-Cell/metabolism , Adult , Animals , Female , Humans , Levilactobacillus brevis/metabolism , Male , Mice , Mice, Inbred NOD , Mice, SCID , NAD/metabolism , Oxidation-Reduction , T-Lymphocytes/metabolism
3.
J Surg Res ; 268: 459-464, 2021 12.
Article in English | MEDLINE | ID: mdl-34416419

ABSTRACT

BACKGROUND: We tracked endocrine surgery patients with treatment delays due to COVID-19 to investigate the relationship between physician assigned priority scoring (PAPS), the Medically Necessary, Time Sensitive (MeNTS) scoring system and delay to surgery. MATERIAL & METHODS: Patients scheduled for endocrine surgery or clinically evaluated during COVID-19-related elective surgery hold at our institution (2/26/20-5/1/20) were prospectively enrolled. PAPS was assigned based on categories of high, moderate, or low risk, consistent with the American College of Surgeons' priority system. MeNTS scores were calculated. The primary outcome was delay to surgery. Descriptive statistics were performed, and receiver operator characteristic (ROC) curves and area under the curve (AUC) values were calculated for PAPS and MeNTS. RESULTS: Of 146 patients included, 68% (n = 100) were female; the median age was 60 years (IQR:43,67). Mean delay to surgery was significantly shorter (P = 0.01) in patients with high PAPS (35 d), compared with moderate (61 d) and low (79 d) PAPS groups. MeNTS scores were provided for 105 patients and were analyzed by diagnosis. Patients with benign thyroid disease (n = 17) had a significantly higher MeNTS score than patients with thyroid disease which was malignant/suspicious for malignancy (n = 44) patients (51.5 versus 47.6, P = 0.034). Higher PAPS correlated well with a delay to surgery of <30 d (AUC: 0.72). MeNTS score did not correlate well with delay to surgery <30 d (AUC: 0.52). CONCLUSION: PAPS better predicted delay to surgery than MeNTS scores. PAPS may incorporate more complex components of clinical decision-making which are not captured in the MeNTS score.


Subject(s)
COVID-19 , Endocrine Surgical Procedures , Adult , Aged , Clinical Decision-Making , Elective Surgical Procedures , Endocrine Surgical Procedures/statistics & numerical data , Female , Humans , Male , Middle Aged
4.
Sci Signal ; 13(625)2020 03 31.
Article in English | MEDLINE | ID: mdl-32234960

ABSTRACT

Clinical response to chimeric antigen receptor (CAR) T cell therapy is correlated with CAR T cell persistence, especially for CAR T cells that target CD19+ hematologic malignancies. 4-1BB-costimulated CAR (BBζ) T cells exhibit longer persistence after adoptive transfer than do CD28-costimulated CAR (28ζ) T cells. 4-1BB signaling improves T cell persistence even in the context of 28ζ CAR activation, which indicates distinct prosurvival signals mediated by the 4-1BB cytoplasmic domain. To specifically study signal transduction by CARs, we developed a cell-free, ligand-based activation and ex vivo culture system for CD19-specific CAR T cells. We observed greater ex vivo survival and subsequent expansion of BBζ CAR T cells when compared to 28ζ CAR T cells. We showed that only BBζ CARs activated noncanonical nuclear factor κB (ncNF-κB) signaling in T cells basally and that the anti-CD19 BBζ CAR further enhanced ncNF-κB signaling after ligand engagement. Reducing ncNF-κB signaling reduced the expansion and survival of anti-CD19 BBζ T cells and was associated with a substantial increase in the abundance of the most pro-apoptotic isoforms of Bim. Although our findings do not exclude the importance of other signaling differences between BBζ and 28ζ CARs, they demonstrate the necessary and nonredundant role of ncNF-κB signaling in promoting the survival of BBζ CAR T cells, which likely underlies the engraftment persistence observed with this CAR design.


Subject(s)
NF-kappa B/immunology , Receptors, Chimeric Antigen/immunology , Signal Transduction/immunology , T-Lymphocytes/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 9/immunology , Cell Line , Humans , Receptors, Chimeric Antigen/genetics , Signal Transduction/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 9/genetics
5.
Sci Rep ; 8(1): 6289, 2018 04 19.
Article in English | MEDLINE | ID: mdl-29674640

ABSTRACT

Etomoxir (ETO) is a widely used small-molecule inhibitor of fatty acid oxidation (FAO) through its irreversible inhibitory effects on the carnitine palmitoyl-transferase 1a (CPT1a). We used this compound to evaluate the role of fatty acid oxidation in rapidly proliferating T cells following costimulation through the CD28 receptor. We show that ETO has a moderate effect on T cell proliferation with no observable effect on memory differentiation, but a marked effect on oxidative metabolism. We show that this oxidative metabolism is primarily dependent upon glutamine rather than FAO. Using an shRNA approach to reduce CPT1a in T cells, we further demonstrate that the inhibition of oxidative metabolism in T cells by ETO is independent of its effects on FAO at concentrations exceeding 5 µM. Concentrations of ETO above 5 µM induce acute production of ROS with associated evidence of severe oxidative stress in proliferating T cells. In aggregate, these data indicate that ETO lacks specificity for CTP1a above 5 µM, and caution should be used when employing this compound for studies in cells due to its non-specific effects on oxidative metabolism and cellular redox.


Subject(s)
Carnitine O-Palmitoyltransferase/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Epoxy Compounds/pharmacology , Oxidative Stress/drug effects , Carnitine O-Palmitoyltransferase/metabolism , Cell Proliferation , Dose-Response Relationship, Drug , Humans , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism
6.
Chem Senses ; 41(4): 281-92, 2016 05.
Article in English | MEDLINE | ID: mdl-26843529

ABSTRACT

(E)-2-alkenals are aldehydes containing an unsaturated bond between the alpha and beta carbons. 2-alkenals are produced by many organisms for defense against predators and secretions containing (E)-2-alkenals cause predators to stop attacking and allow the prey to escape. Chemical ecologists have described many alkenal compounds with 3-20 carbons common, having varied positions of double bonds and substitutions. How do these defensive alkenals act to deter predators? We have tested the effects of (E)-2-alkenals with 6-12 carbons on transient receptor potential channels (TRP) commonly found in sensory neurons. We find that (E)-2-alkenals activate transient receptor potential ankyrin subtype 1 (TRPA1) at low concentrations-EC50s 10-100 µM (in 0 added Ca(2+) external solutions). Other TRP channels were either weakly activated (TRPV1, TRPV3) or insensitive (TRPV2, TRPV4, TRPM8). (E)-2-alkenals may activate TRPA1 by modifying cysteine side chains. However, target cysteines include others beyond the 3 in the amino-terminus implicated in activation, as a channel with cysteines at 621, 641, 665 mutated to serine responded robustly. Related chemicals, including the aldehydes hexanal and decanal, and (E)-2-hexen-1-ol also activated TRPA1, but with weaker potency. Rat trigeminal nerve recordings and behavioral experiments showed (E)-2-hexenal was aversive. Our results suggest that TRPA1 is likely a major target of these commonly used defensive chemicals.


Subject(s)
Action Potentials/drug effects , Aldehydes/pharmacology , Calcium Channels/metabolism , Nerve Tissue Proteins/metabolism , Transient Receptor Potential Channels/metabolism , Trigeminal Nerve/drug effects , Aldehydes/chemistry , Animals , Calcium/metabolism , Calcium Channels/genetics , Cysteine/metabolism , HEK293 Cells , Habituation, Psychophysiologic/drug effects , Hexanols/chemistry , Hexanols/pharmacology , Humans , Male , Microscopy, Fluorescence , Nerve Tissue Proteins/genetics , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , TRPA1 Cation Channel , Transient Receptor Potential Channels/genetics , Trigeminal Nerve/physiology
7.
J Mol Cell Cardiol ; 78: 3-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25463276

ABSTRACT

Calcium influx into the mitochondrial matrix plays important roles in the regulation of cell death pathways, bioenergetics and cytoplasmic Ca(2+) signals. During the last few years, several molecular components of the inner membrane mitochondrial Ca(2+) uniporter, the dominant pathway for Ca(2+) influx into the mitochondrial matrix, have been identified. The uniporter is now recognized as a complex of proteins that include a Ca(2+) pore forming component and accessory proteins that are either required for its channel activity or regulate it under various conditions. This review summarizes recent discoveries about the molecular basis of the uniporter complex. This article is part of a Special Issue entitled "Mitochondria: From Basic Mitochondrial Biology to Cardiovascular Disease."


Subject(s)
Calcium Channels/metabolism , Calcium/metabolism , Mitochondria/metabolism , Animals , Calcium-Binding Proteins/metabolism , Humans , Mitochondrial Membrane Transport Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...